Technical Analysis for HRTX - Heron Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 3.20 | -0.62% | -0.02 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -0.62% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Possible Pocket Pivot | 1 day ago |
| Up 2% | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| 3x Volume Pace | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 06/13/2024
Heron Therapeutics, Inc. Description
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Cancer Treatment Oncology Chemotherapy Antineoplastic Drugs Occupational Safety And Health Drug Delivery Nausea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.29 |
| 52 Week Low | 0.5 |
| Average Volume | 2,515,125 |
| 200-Day Moving Average | 1.89 |
| 50-Day Moving Average | 2.78 |
| 20-Day Moving Average | 2.74 |
| 10-Day Moving Average | 2.95 |
| Average True Range | 0.22 |
| RSI (14) | 64.54 |
| ADX | 20.72 |
| +DI | 28.39 |
| -DI | 11.64 |
| Chandelier Exit (Long, 3 ATRs) | 2.62 |
| Chandelier Exit (Short, 3 ATRs) | 2.94 |
| Upper Bollinger Bands | 3.24 |
| Lower Bollinger Band | 2.24 |
| Percent B (%b) | 0.96 |
| BandWidth | 36.65 |
| MACD Line | 0.10 |
| MACD Signal Line | 0.04 |
| MACD Histogram | 0.059 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.37 | ||||
| Resistance 3 (R3) | 3.38 | 3.34 | 3.34 | ||
| Resistance 2 (R2) | 3.34 | 3.29 | 3.33 | 3.33 | |
| Resistance 1 (R1) | 3.27 | 3.27 | 3.26 | 3.26 | 3.32 |
| Pivot Point | 3.22 | 3.22 | 3.22 | 3.22 | 3.22 |
| Support 1 (S1) | 3.15 | 3.18 | 3.14 | 3.14 | 3.08 |
| Support 2 (S2) | 3.11 | 3.15 | 3.10 | 3.07 | |
| Support 3 (S3) | 3.04 | 3.11 | 3.06 | ||
| Support 4 (S4) | 3.03 |
